91 related articles for article (PubMed ID: 2199426)
21. Gemfibrozil reduces small low-density lipoprotein more in normolipemic subjects classified as low-density lipoprotein pattern B compared with pattern A.
Superko HR; Berneis KK; Williams PT; Rizzo M; Wood PD
Am J Cardiol; 2005 Nov; 96(9):1266-72. PubMed ID: 16253595
[TBL] [Abstract][Full Text] [Related]
22. [Statistical analysis of variations in total cholesterol, HDL, HDL2, HDL3, LDL-cholesterol, VLDL-triglycerides, apo-A and apo-B lipoproteins in dyslipidemias during antilipemic therapy].
Melloni GF; Scarazatti E; Garanzelli P; Melloni R
Boll Soc Ital Biol Sper; 1985 Jan; 61(1):7-14. PubMed ID: 3884023
[TBL] [Abstract][Full Text] [Related]
23. Relation between baseline lipid and lipoprotein values and the incidence of coronary heart disease in the Helsinki Heart Study.
Manninen V; Huttunen JK; Heinonen OP; Tenkanen L; Frick MH
Am J Cardiol; 1989 May; 63(16):42H-47H. PubMed ID: 2650524
[TBL] [Abstract][Full Text] [Related]
24. [Multicenter study of the efficacy and tolerance of gemfibrozil and fenofibrate in the treatment of primary hyperlipoproteinemia].
Manojlović D; Lepsanović L; Micić D; Sumarac M; Kendereski L; Popović V; Mićić J
Srp Arh Celok Lek; 1991; 119(1-2):22-5. PubMed ID: 1788614
[TBL] [Abstract][Full Text] [Related]
25. Gemfibrozil in familial and type V hyperlipidaemias. Report of 3 cases.
Varthakavi P; Turakhia DP; Sharma S; Salgaonkar DS; Nihalani KD; Joshi VR
J Assoc Physicians India; 1990 Nov; 38(11):860-2. PubMed ID: 2079473
[TBL] [Abstract][Full Text] [Related]
26. Gemfibrozil. A reappraisal of its pharmacological properties and place in the management of dyslipidaemia.
Spencer CM; Barradell LB
Drugs; 1996 Jun; 51(6):982-1018. PubMed ID: 8736620
[TBL] [Abstract][Full Text] [Related]
27. A long-term trial of gemfibrozil in the treatment of hyperlipidaemias.
Eisalo A; Manninen V
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):49-52. PubMed ID: 798198
[No Abstract] [Full Text] [Related]
28. Gemfibrozil and clofibrate in the treatment of hyperlipidaemias. A comparative trial.
Eisalo A; Manninen V
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):44-6. PubMed ID: 798196
[No Abstract] [Full Text] [Related]
29. Hyperlipidemia after renal transplantation: treatment with gemfibrozil.
Chan TM; Cheng IK; Tam SC
Nephron; 1994; 67(3):317-21. PubMed ID: 7936022
[TBL] [Abstract][Full Text] [Related]
30. Gemfibrozil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in dyslipidaemia.
Todd PA; Ward A
Drugs; 1988 Sep; 36(3):314-39. PubMed ID: 3056692
[TBL] [Abstract][Full Text] [Related]
31. [The effect of gemfibrozil on serum apo C II and C III in diabetic hyperlipidemia].
Tong N; Liang J
Hua Xi Yi Ke Da Xue Xue Bao; 1991 Sep; 22(4):409-11. PubMed ID: 1814823
[TBL] [Abstract][Full Text] [Related]
32. Normocholesterolaemic dyslipidaemia: is there a role for fibrates?
Tallis GA
Med J Aust; 2001 Jun; 174(11):610; author reply 611. PubMed ID: 11453340
[No Abstract] [Full Text] [Related]
33. The effects of gemfibrozil upon the hypercoagulable state in dyslipidaemic patients with chronic renal failure.
Irish AB; Thompson CH
Nephrol Dial Transplant; 1996 Nov; 11(11):2223-8. PubMed ID: 8941582
[TBL] [Abstract][Full Text] [Related]
34. [Therapeutic effects of nicofibrate on diabetic hyperlipemia].
Gragnoli G; Postorino G; Tanganelli I; Brandi L
Minerva Med; 1977 Apr; 68(19):1281-92. PubMed ID: 323747
[TBL] [Abstract][Full Text] [Related]
35. Gemfibrozil in the treatment of dyslipidaemias in middle-aged male survivors of myocardial infarction.
Kaukola S; Manninen V; Mälkönen M; Ehnholm C
Acta Med Scand; 1981; 209(1-2):69-73. PubMed ID: 7010929
[TBL] [Abstract][Full Text] [Related]
36. [Cholestyramine as a cholesterol lowering preparation. A clinical evaluation].
Bye A; Brox D
Tidsskr Nor Laegeforen; 1976 Jun; 96(16):928-9. PubMed ID: 779134
[No Abstract] [Full Text] [Related]
37. [Effect of hexanicotinate of meso-inositol in patients with primary hyperlipidemia (author's transl)].
Agusti R; Jordán C; Aste H; Tapia F
Rev Invest Clin; 1978; 30(4):327-35. PubMed ID: 362498
[No Abstract] [Full Text] [Related]
38. Efficacy of gemfibrozil in dyslipidaemic subjects with suspected heart disease. An ancillary study in the Helsinki Heart Study frame population.
Frick MH; Heinonen OP; Huttunen JK; Koskinen P; Mänttäri M; Manninen V
Ann Med; 1993 Feb; 25(1):41-5. PubMed ID: 8435186
[TBL] [Abstract][Full Text] [Related]
39. Influence of chenodeoxycholic acid on serum triglycerides in patients with primary hypertriglyceridemia.
Camarri E; Fici F; Marcolongo R
Int J Clin Pharmacol Biopharm; 1978 Nov; 16(11):523-6. PubMed ID: 365796
[TBL] [Abstract][Full Text] [Related]
40. [Results and prospects of therapy of type IV dyslipidemia with chenic acid].
Camarri E; Marcolongo R; Marini G; Zaccherotti L
Minerva Med; 1978 May; 69(23):1561-74. PubMed ID: 210428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
